Eomaia is a startup based in France. Brouky records 1 investor associated with the company.
Eomaia develops Mammex, a medical device to assist mothers and healthcare professionals with the expression and collection of colostrum in neonatal contexts such as prematurity, cesarean births, and mother–baby separation. The company provides educational and clinical support materials for use by parents and healthcare teams.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.